HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of the reversible monoamine oxidase-A inhibitor brofaromine in social phobia complicated by panic disorder with or without agoraphobia.

AuthorsD Bakish
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 14 Issue 1 Pg. 74-5 (Feb 1994) ISSN: 0271-0749 [Print] United States
PMID8151007 (Publication Type: Case Reports, Clinical Trial, Letter, Randomized Controlled Trial)
Chemical References
  • Monoamine Oxidase Inhibitors
  • Piperidines
  • brofaromine
Topics
  • Adult
  • Agoraphobia (drug therapy, psychology)
  • Humans
  • Male
  • Monoamine Oxidase Inhibitors (adverse effects, therapeutic use)
  • Panic Disorder (drug therapy, psychology)
  • Phobic Disorders (drug therapy, psychology)
  • Piperidines (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: